Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.
20h
The Brighterside of News on MSNRevolutionary new cancer treatment destroys tumors in less than 6 daysResearchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...
16hon MSN
San Luis Obispo County residents responded to a survey sent by The Tribune about difficulties accessing primary care here in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results